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Abstract
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy facilitated by Epstein-Barr Virus infection. Here we resolve the
major genetic influences for NPC incidence using a genome-wide association study (GWAS), independent cohort replication,
and high-resolution molecular HLA class I gene typing including 4,055 study participants from the Guangxi Zhuang
Autonomous Region and Guangdong province of southern China. We detect and replicate strong association signals
involving SNPs, HLA alleles, and amino acid (aa) variants across the major histocompatibility complex-HLA-A, HLA –B, and
HLA -C class I genes (PHLA-A-aa-site-62 = 7.4610229; P HLA-B-aa-site-116 = 6.5610219; P HLA-C-aa-site-156 = 6.861028 respectively). Over
250 NPC-HLA associated variants within HLA were analyzed in concert to resolve separate and largely independent HLA-A, B, and -C gene influences. Multivariate logistical regression analysis collapsed significant associations in adjacent genes
spanning 500 kb (OR2H1, GABBR1, HLA-F, and HCG9) as proxies for peptide binding motifs carried by HLA- A*11:01. A similar
analysis resolved an independent association signal driven by HLA-B*13:01, B*38:02, and B*55:02 alleles together. NPC
resistance alleles carrying the strongly associated amino acid variants implicate specific class I peptide recognition motifs in
HLA-A and -B peptide binding groove as conferring strong genetic influence on the development of NPC in China.
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genetic markers implicated as associated with NPC, the highly
variable class I human leukocyte antigen (HLA) genes on
chromosome 6 (6p21.3) have shown a strong and consistent
association with NPC risk. [7,8,9,10,11,12,13]_ENREF_7 HLA
class I association studies across mainland China [11,13], Taiwan
[10,12], and Singapore [8] have consistently demonstrated that
HLA-A*11 and B*13 are associated with NPC resistance, while
A*02 (A*02:07), A*33, B*46 and B*58 are associated with increased
NPC susceptibility (Table S1). Genome-wide association studies
(GWAS) have been applied to numerous complex diseases to
implicate common risk variants through well powered genetic
studies [14,15,16]. Recent GWAS also affirmed a strong HLA
influence on NPC incidence and implicated four additional nonHLA genes, however extensive linkage disequilibrium across the

Introduction
Nasopharyngeal carcinoma (NPC) is an epithelial malignancy
with highly variable incidence rates around the world. An estimated
84,400 incident cases of NPC and 51,600 deaths occurred in 2008
with the highest incidence in South-Eastern Asia, relative to the
Americas, Europe, Africa, and Central and Eastern Asia [1]. An
early indicator of NPC development is the occurrence of
immunoglobulin (Ig)A antibodies to Epstein-Barr virus (EBV)
capsid antigens (EBV-IgA/VCA). [2,3] NPC incidence for individuals expressing IgA/VCA antibodies were 31.7 times higher than
the incidence in the age matched general population. [4] Linkage
and family studies indicated that genetic predisposition also plays an
important role in NPC onset and susceptibility. [5,6] Among host
PLOS Genetics | www.plosgenetics.org
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wide significant NPC association and replication were within
500 kb of each other in the MHC region of chromosome 6
(Table 1, Table S7). The most significant SNP rs417162
(Pcombined = 1.1610211, OR = 0.61) is located within the HLA-A
locus, while four additional replicated SNPs were within adjacent
genes, GABBR1 and HCG9.
A fine-grain view of the pattern of GWAS SNPs around the
HLA-A locus is illustrated in Figure 1B. An extensive cluster of
associated HLA-A region SNPs that approach or exceed genomewide association threshold p-values (p,1028) is apparent within
500 kb including associations in the adjacent HCG9 and GABBR1
genes (Figure 1C). The strong linkage disequilibrium (LD) across
the HLA region is well known, which raises the question whether
these HLA region associations represent single, multiple independent, or LD-proxy driven associations.
To characterize the HLA association with NPC in finer detail,
high-resolution molecular HLA genotyping was performed on
4055 study participants; 1043 subjects in the discovery cohort, 985
subjects in the replication cohort, and 2027 subjects that comprise
the remainder of cohort (Table S3). [20,21] NPC cases, controls
with EBV-IgA/VCA positive, and controls with EBV-IgA/VCA
negative were examined for association of HLA alleles and HLA
haplotypes with NPC risk and EBV IgA/VCA antibody status.
Three HLA alleles, A*11:01, B*38:02 and B*55:02 showed the
most significant association with NPC (P = 1.7610219,
P = 7.0610211, and P = 1.6610210 respectively; Table 2). In
addition to the strong HLA-A and -B associations, there was a
moderate association of HLA-C*12:02 allele as well (P = 4.361025;
Table 2). NPC associated HLA-A-B-C haplotypes which included
HLA allele combinations from Table 2 were also apparent (Table
S8).
Functional variation of different MHC molecules to bind
peptides and activate effector cells in the immune system underlies
their association with disease. [22,23]_ENREF_18 To identify the
specific site driving the NPC HLA associations, HLA gene
sequence was translated to identify amino acid variants using a
web-based software of the Immunology Database and Analysis
Portal (ImmPort) system [24]. Genetic association of 284 detected
HLA amino acid variant within the three HLA class I genes
implicated the most significant NPC association of glutamine (Gln,
Q) at amino acid position 62 of HLA-A gene (P = 1.2610224,
OR = 0.59; Figure 2A; Tables S9 and S10) which marks HLAA*11, however there are 25 additional amino acid sites I in HLA-A
that also show exceed genome wide significance (P,_ENREF_181028; Figure 2A). The HLA-B signal centered on amino
acid Leucine (Leu, L) at amino acid position 216 and 116
(P = 1.7610213 and 2.4610213, OR = 0.65 and 0.63; Table S10),
which marks B*13:01 and B*55:02. A far less significant
association was observed for the amino acid residue Tryptophan
(Trp, W) at amino acid position 156 for HLA-C (P = 1.461029,
OR = 0.47;). Amino acid residues that correspond to the antigenic
peptide binding groove residues showed the strongest association
(See color code in Figure 2A–2C) suggesting that the peptide
binding groove and function are major genetic factors for NPC
risk.
Given the plethora and complexity of HLA genetic associations
plus the extensive LD within HLA, we attempted to resolve which
HLA region SNPs and aa-variants represent proxy variants for one
or more functional sites (i.e. they were tracking by LD) and which
represent independent (non-LD) association signals using a
multivariate logistic regression analyses [25]. Strongly associated
aa-variants (Figure 2 and in Tables S9 and S10; e.g HLA-A-62Gln)
were analyzed in a multivariate logistical regression analysis
adjusting statistically for non-random influence of each of the

Author Summary
NPC is a deadly throat cancer in China that is dependent
on EBV infection. Here, we performed a 1 M SNP genomewide association study using a large cohort of Chinese
study participants at risk for NPC. Although several
putative gene regions show significant associations, the
strongest statistical signals involved scores of variants
within the HLA region on chromosome 6. HLA poses a
formidable association-genetics challenge because of
extensive linkage disequilibrium, rather low allele frequencies, and multiple physically close interacting genes of
diverse function. We examined over 250 NPC-HLA associated variants detected with sequence-based nucleotide
alleles and amino acid variants. The multiple associations
were collapsed to implicate causal signals by multivariate
logistical regression to resolve allele association interaction. One operative variant was identified as the HLAA*11:01 allele motif, specifically in the peptide binding
groove, which recognizes invading antigens; a second
involved two aa sites with HLA-B tracking B*13:01 and
B*55:02 alleles. We synthesize these new and previous
discoveries to help resolve the important gene influences
on this disease.

gene dense HLA region have confounded identification of the
causal association gene(s). [17,18,19]
To refine and extend these reports, we explore here the
operative factors of genetic association for this disease in a
comprehensive four step study utilizing: 1) A GWAS utilizing
591,458 SNPs resolved by Affymetrix 6.0 genotyping platform to
identify gene regions associated with NPC; 2) SNP genotyping to
replicate the top signals in a second independent NPC cohort; 3)
High resolution HLA molecular genotyping to identify specific
alleles and haplotypes associated with NPC; and 4) Amino acid
variant analysis to fine map the major genetic determinants
associated with this disease. The analyses demonstrates that two
independent association signals, specifying peptide binding grove
motifs in HLA-A and in HLA –B drive the signals tracked by
scores of SNP and amino acid variants that are association proxies
for the HLA class I NPC association.

Results
We performed a GWAS with 1104 southern Chinese individuals from NPC-phase II study cohorts [20,21] (See Materials and
Methods) using the Affymetrix Genome-Wide SNP 6.0 genotyping
platform. After SNP- and sample-base quality control (Table S2),
591,458 SNPs genotyped in 1043 study participants (567 cases and
476 controls; Table S3, line I). Principal components analysis
confirmed that all samples came from individuals of Southern
Chinese ancestry (Figures S1, S2, S3, S4, S5). A quantile-quantile
plot of the observed p-values showed a clear deviation from the
null distribution which suggested that the most significant lower pvalues are smaller than those expected by chance and likely reflect
genetic association (Figure S6). The GWAS allele associations
suggested a strong influence in the HLA-A region of chromosome 6
and weaker signals on chromosome 16 and 17 (Figure 1A).
Twenty-four SNPs (Table S4) with p-values less than 561025 in
16 association tests (Table S5) and sixteen previous GWAS
reported NPC associated SNPs (Table S6) and were selected for
replication. Replication SNP genotyping was conducted in an
independent Chinese cohort that included 356 NPC cases and 629
controls (Table S3, line II). Six of 40 SNPs that showed genomePLOS Genetics | www.plosgenetics.org
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Figure 1. NPC associations of GWAS and Taqman validation. A.) Manhattan plot of GWAS P value association results of 591,458 SNP allele
genotypes versus chromosome coordinate position (N = 1043 study participants; Row I in Table S3). Association p-values (-log10 transformed) are
calculated by logistic regression in additive logistic model and plotted by genomic position. Association p-values for HLA SNP that were assessed by
HLA sequence base typing for the same 1043 individuals are indicated by open red triangles (see text). B.) NPC association signal for significant HLA
alleles (left) and included SNP variants on Chromosome 6.The –log10 p values, calculated with the logistic regression model, in GWAS and combined
association tests are shown, SNPs are ordered according to the location on chromosome 6 HLA-A region. Color coded indicate the LD value (r2) of
each variant with the most significant SNP rs417162. C.) Disequilibrium coefficient values for SNPs genotyped in the HLA region for NPC GWAS
(N = 1043), generated with the use of Haploview software.
doi:10.1371/journal.pgen.1003103.g001

adjacent aa-variants (Figure 3; also in Table S11). A dramatic
reduction of association p-value significance for the strongest
HLA-A aa variant, HLA-A-62Gln, is observed when this model is
PLOS Genetics | www.plosgenetics.org

adjusted for adjacent aa-variants within and about the HLA-A
gene but are not diminished by adjusting for variants in HLA-B or
HLA-C. Thus, we conclude that there is a single association signal
3
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Table 1. GWAS and validation of SNPs association data in two independent NPC cohorts.

GWAS (N = 1,043)

Validation (N = 985)

Combined (N = 2,028)

SNP name

Gene

Chr.

MA{

MAF{

P-value

OR(95% CI)

MAF

P-value

OR(95% CI)

P-value

OR (95% CI)

rs417162

HLA-A

6

C

0.26/0.37

1.13E-07

0.58(0.48–0.71)

0.26/0.35

3.75E-05

0.63(0.50–0.78)

1.05E-11

0.63(0.53–0.75)

rs2517713*

HLA-A

6

G

0.26/0.37

3.03E-07

0.57(0.46–0.71)

0.26/0.35

2.61E-05

0.62(0.50–0.78)

1.63E-11

0.60(0.52–0.70)

*

HCG9

6

A

0.22/0.32

5.90E-07

0.57(0.45–0.71)

0.21/0.32

1.32E-05

0.59(0.47–0.75)

2.63E-11

0.59(0.50–0.69)

rs5009448*

HCG9

6

T

0.26/0.35

1.09E-05

0.63(0.51–0.77)

0.24/0.35

4.43E-07

0.56(0.45–0.70)

6.40E-11

0.61(0.53–0.71)

rs2267633

GABBR1

6

G

0.17/0.26

1.43E-06

0.58(0.47–0.73)

0.17/0.24

2.77E-04

0.63(0.49–0.81)

1.89E-09

0.61(0.52–0.72)

rs29230*

GABBR1

6

C

0.17/0.25

2.37E-05

0.60(0.47–0.76)

0.17/0.24

6.02E-04

0.65(0.50–0.83)

9.48E-09

0.61(0.52–0.72)

rs9260734

*: Replication SNPs that not included in Affymetrix Genome-Wide SNP Array;
{
: MA, Minor allele;
{
: MAF, Minor allele frequencies;
doi:10.1371/journal.pgen.1003103.t001

in HLA-A tracked by several dozen proxy aa/SNP variants within
the HLA-A region. When HLA-A*11:01 is the index allele, the
extreme NPC association signal is diminished to 0.1–0.01 by HLAA aa variants as well as each SNP in the genes adjacent to HLA-A
locus (See Figure 3B and HLA-A*11:01 column in Table S11).
This multivariate dependence plus the knowledge that HLAA*11:01 carries the five strongly significant associated aa variants
(62Gln, 276Leu, 114Arg, 70Gln, and 97Ile) in the peptide binding
groove and reaches the highest significance in allele level would
support the conclusion that the causal association is driven by the
HLA-A*11:01 allele (Table 2, Table S10, Figure S7).
A multivariate logistical regression analysis for HLA-B variants
indicates that HLA-B associations are independent from the HLA-A
signals and driven by two amino acid sites in strong LD with each
other (HLA-B: -16Leu and 116Leu; P = 1.7610213 and 2.4610213)
(Figure 3C and Table S9). The most significant HLA-B signal is
located at amino acid position 116 (Figure 2B). The amino acid
variant HLA-B-116Leu is present in the two strongly associated
protective HLA-B alleles B*13:01 and B*55:02, but the encoded
amino acid in the associated suscetible allele HLA-B*38:02 is
Phenylalanine (Table S9). It is also relevant that the same location of
HLA-B amino acid position 116 has also been definitively implicated
as the single aa site that drives high susceptibility of the HLA-B*35
association with very rapid AIDS progression in HIV-1 infected
European Americans. [26,27] It seems that this variant influences
HLA peptide repertoire recognition and/or presentation for both
HIV and EBV infections. The amino acid substitution in the heavy
chain at position 116 could abolish the ability of P9 picket of HLAB*35:01 to bind tyrosine but preferentially accommodate smaller
hydrophobic residues such as methionine, valine, or leucine at the
carboxy-terminal anchor had been shown by peptide-binding
assays. [28]
The HLA-C signal is ten logs weaker than HLA-A or HLA-B
and is diminished slightly by adjusting for HLA-A or HLA-B
variants (Figure 3E, Table S11). Further, the most significant
HLA-C alleles (HLA-C*03:02 and -C*12:02) track HLA-A and -B
alleles in the haplotype analyses (Table S8), suggesting the HLA-C
association are likely proxies of the stronger HLA-B and -A
associations. We interpret these cumulative data as suggestive that
there are two robust independent HLA association signals with
NPC development: HLA-A including at least five amino acid
position in 62Gln, 70Gln, 97Ile, 114Arg and 276Leu carried by
HLA-A*11:01 and HLA-B including the -16Leu and 116Leubearing alleles.
Our GWAS analysis also provided an opportunity to inspect
regions of the genome outside HLA that had been implicated in
PLOS Genetics | www.plosgenetics.org

previous NPC studies. The results (Table S6 and Table 1) offer
strong supportive confirmation of SNPs in the HLA-A gene region
(including the adjacent HCG9, and GABBR1 genes) as suggested by
previous GWAS. [18,19] However, our SNP replication (Table
S6) and multivariate logistical regression analysis (Figure 3; Table
S11) indicate that all these associations are by and large proxies for
the primary functional aa variants association in our cohort. We
also replicated the TNFRSF19, MDS1-EVI1, CDNK2A/2B gene
associations [19] in our cohort (p = 1.561025; 5.061025 and
5.661023 respectively) although these genes did not achieved
genome wide significance (Table S6). The ITGA9 association
reported by Ng et al14 was not replicated in our cohort (Table S6).

Discussion
We present and interpret a 1 M SNP GWAS, in subjects from
Guangxi Zhuang Autonomous Region and Guangdong province of
southern China, where perhaps the highest recorded NPC
incidence has been found. [3,4,20,21] Multiple genome wide
significant association signals were evident with the HLA gene
region and in a few other chromosomal regions (Figure 1A). Because
the HLA region is complex and displays extensive LD, we sought to
resolve the causal association signals with several different
approaches. These included replication in an independent cohort
from the same area, sequence based gene typing of the HLA-A, -B
and -C genes, and analysis of sequence based nucleotide alleles as
well as 284 amino acid site variants across the HLA genes (Figure 2).
We compared association signals of SNPs, aa variants, HLA- alleles
defined by molecular typing and associated HLA –A, -B and C
haplotypes. To resolve the operative variants from proxies that track
signals by LD, we enlisted a multivariate logistical regression of
alleles and site variants with the strongest signals (Figure 3, Table
S11). Finally we revisited and attempted replication in our cohort
reports from other NPC gene associations including GWAS recently
published, [17,18,19] (TNFRSF19 -CHR 13, MDS1-EVI1-CHR
3, and CDNK2A/2B- CHR 9; Table S6) affirming gene influence
that are important in this disease.
In the present study, two independent powerful association
signals within the HLA region were resolved for NPC, amidst a
background of scores of adjacent associated LD-proxy variants.
The first influence involved the HLA-A*11:01 allele sequence and
function, specifically in the peptide binding groove, which
recognizes invading antigens. This conclusion derives from several
lines of evidence: 1.) HLA-A*11:01 is a common allele in the
populations (F = 0.25) and is the only ‘‘protective’’ allele with
genome wide significant HLA-A signal (OR = 0.59; P = 1.7610219;
4
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.[VQ]……[VS]

.[L-]……[VL]

.[YT]……[K-]

[DE]I……[R-]

02:07

11:01

33:03

5

R[R-]……[LF]

.[–]……[–]

.[MI]……[YF]

.[P-]……[AV]

.[TS]……[WF]

27:04

38:02

46:01

55:02

58:01

16.37(460)
21.64(608)
0.93(26)
0.78(22)

07:02

12:02

12:03

2.14(55)

1.59(41)

16.89(435)

15.22(392)

21.35(550)

15.49(399)

3.38(75)

17.97(463)

6.83(176)

0.97(25)

12.27(316)

15.76(406)

30.12(776)

13.32(343)

2.21(57)

10.87(280)

EP. Controls{
(N = 1288)

1.76(48)

2.83(77)

19.38(528)

11.97(326)

17.99(490)

12.22(333)

3.67(100)

14.46(394)

8.48(231)

1.69(46)

10.87(296)

12.37(337)

29.11(793)

11.56(315)

3.01(82)

15.01(409)

EN. Controls{
(N = 1362)

0.41(0.25–0.65)

0.41(0.27–0.63)

1.25(1.11–1.40)

1.28(1.12–1.46)

1.47(1.26–1.71)

0.27(0.18–0.40)

1.67(1.43–1.94)

0.66(0.56–0.77)

1.36(1.19–1.54)

0.59(0.53–0.66)

1.38(1.21–1.57)

1.65(1.28–2.13)

OR (95% CI.)

NPC vs. Control

1.47E-04

4.28E-05

1.84E-04

2.05E-04

Ns

2.38E-04

1.57E-10

Ns

6.96E-11

Ns

4.52E-07

3.14E-06

1.72E-19

1.52E-06

1.15E-04

Ns

P Value

0.37(0.22–0.62)

1.37(1.19–1.58)

0.28(0.18–0.43)

1.88(1.55–2.28)

0.62(0.51–0.74)

0.57(0.50–0.65)

1.91(1.38–2.65)

1.52(1.29–1.79)

OR (95% CI.)

1.37E-04

Ns

1.65E-05

Ns

Ns

Ns

7.38E-09

Ns

1.96E-10

Ns

3.15E-07

Ns

1.43E-16

Ns

1.00E-04

4.49E-07

P Value

NPC VS. EP. Controls

0.31(0.20–0.49)

1.48(1.26–1.73)

1.28(1.12–1.46)

1.43(1.23–1.67)

0.26(0.17–0.40)

1.39(1.21–1.60)

1.51(1.26–1.80)

0.31(0.17–0.55)

0.71(0.59–0.86)

1.57(1.35–1.84)

0.61(0.53–0.69)

1.49(1.28–1.74)

OR (95% CI.)

Ns

4.14E-07

Ns

1.30E-06

2.16E-04

1.47E-06

5.02E-10

4.77E-06

5.90E-06

8.56E-05

3.16E-04

1.01E-08

3.13E-14

3.98E-07

Ns

Ns

P Value

NPC VS. EN. Controls

*: Amino acid motifs from Lund et al., 2004.
{
: EP. controls, the controls of NPC free and EBV IgA/VCA antibody positive.
{
: EN. controls, the controls of NPC free and EBV IgA/VCA antibody negative.
1
: Allele also showed significant in the comparison of EP. controls VS. EN. controls, p = 7.81E-06, OR = 0.69(0.59–0.81).
#
A preliminary analysis of HLA association in phase I was previously reported (Tang et al., 2010). Now, HLA associations with phase I and phase II (See Materials and methods) are presented separately in Table S12.
doi:10.1371/journal.pgen.1003103.t002

22.03(619)

03:02

16.65(468)

1.00(28)

19.18(539)

12.21(343)

0.53(15)

8.04(226)

17.69(497)

20.25(569)

16.48(463)

2.62(139)

15.80(444)

NPC Patients
(N = 1405)

01:02

HLA-C

.[–]……[–]

13:01

HLA-B

.[LV]……[LI]

02:06

Amino Acid Binding
Motifs*

02:031

HLA-A

Allele Name

Allele Frequencies

Table 2. Gene frequencies (%) of the HLA-A, -B, and -C alleles detected and association analysis (N = 4,055).#
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Figure 2. NPC associations of HLA alleles and amino acid variants. A.) NPC associations of alleles and amino acid variants at HLA-A locus; B.)
NPC associations of alleles and amino acid variants at HLA-B locus; C.) NPC associations of alleles and amino acid variants at HLA-C locus. Genetic
association of HLA alleles and amino acid sites were calculated (N = 4055 study participants; Line V in Table S3). For amino acid positions with more
than two alleles, p-value for the omnibus test that tests all amino acid alleles simultaneously (with .1 degrees of freedom) for association to control.
doi:10.1371/journal.pgen.1003103.g002

phases: phase I -April 2000 to June 2001 and phase II-November
2004 to October 2005, from the Guangxi autonomous region and
Guangdong province of southern China. [20] All study subjects
were of Han ethnic origin and reside in the catchment area of the
Xijiang River. IgA antibodies to EBV capsid antigen (EBV-IgA/
VCA) were confirmed by serologic testing for all the subjects at the
time of study enrollment. In phase I, the case group included 356
unrelated patients with biopsy-confirmed NPC. The mean age was
50.1 years (range 19–80), 95.5% of them were EBV-IgA/VCA
antibody positive. Controls included case spouses or geographically matched residents who were NPC free at the time of study
enrollment. An additional 422 adult children of the study subjects
were enrolled for haplotype inference and for quality control
assessment, but they were excluded in association analyses. In
phase II, the case group included 1049 unrelated patients with
biopsy-confirmed NPC. The mean age was 46.3 years (range 10–
77), 96.3% of them were EBV-IgA/VCA antibody positive. Two
distinct NPC-free control groups were included; one group was
positive (N = 1001) and the other negative (N = 1020) for the EBVIgA/VCA antibody. The mean ages were 46.1 and 46.6, for the
antibody positive and negative controls groups. All study subjects
were self-reported Guangxi or Guangdong provincial ancestry for
either maternal or paternal ancestry for at least three generations.

Table 1) the strongest of all HLA alleles. 2.) HLA-A*11:01 is
included in the significantly associated protective HLA haplotypes
(Table S8); 3.) 100% of associated SNPs and aa variants about
HLA-A, including those in adjacent genes, namely the HCG9, and
GABBR1 loci, are proxies HLA-A*11:01(Figure 3; Table S11); 4.)
HLA-A*11:01 carries five strongly significant associated aa
variants (62Gln, 276Leu, 114Arg, 70Gln, and 97Ile) in its peptide
binding groove (Table S10). Taken together, the HLA-A
association is centered on HLA-A*11:01 allele function and
tracked by internal and closely linked proxy aa and SNP variants.
It may also be relevant that the sequence of HLA-A*11:01 allele
(F = 0.25 in this population) differs by only one amino acid residue
(Lys19Glu) from that of the HLA-A*11:02 allele (F = 0.04), yet
HLA-A *11:02 shows no apparent association with NPC onset.
Both HLA-A*11:01 and HLA-A*11:02 alleles share a unique
peptide binding motif signature of ‘‘.[YT]……[K-]’’ (Table 2) and
an identical sequence within the defined residues of the antigen
recognition site. [23] Since the only Lys19Glu residue difference
between the two HLA-A*11 alleles is outside the peptide binding
region, the possibility of an alternative mechanisms for NPC
pathogenesis, e.g. HLA-A/KIR innate immunity involvement [29]
or dendritic cell interaction, [30] should be considered and
explored in future studies.
We further demonstrate an independent HLA-B signal derived
from three representive alleles, two protective alleles (B*13:01 and
B*55:02) and a suscetible allele B*38:02. Both HLA-A and -B
associations involve functional variants in the antigenic recognition
site. The strongest HLA-B aa site implicated is identical to the
single aa site that mediates HLA-B*35 rapid AIDS progression
reported previously. [26,27,30] All the NPC associations were
genome wide significant in one or more analyses, replicated
internally in independent Guangxi cohorts and externally in other
genetic association studies in Asia. Our study demonstrates a
powerful genetic influence on NPC onset in Chinese people,
implicates explicit HLA alleles, peptide recognition motifs, and aa
variants that confer strong genetic influence on the development of
NPC in China. HLA disease associations are likely to involve
multiple mechanisms. A recent study in HIV disease showed that
allelic diversity of HLA-C can cause variation in the level of
surface expression of the HLA-C molecule, which in turn affects
viral load control and disease progression [31], perhaps through
both HLA-restricted CTL responses and HLA/KIR-mediated
NK cell activities. The functional basis for HLA associations with
NPC should be explored fully, now that the genetic basis of this
disease is well-characterized, in hopes of explaining the complex
HLA association with NPC in the Chinese population.

Genome-wide SNPs genotyping
A total of 598 NPC cases and 506 controls were randomly
selected from phase II enrollment cohort for GWAS analysis.
DNA was extracted from whole blood by traditional phenol/
chloroform method with phase Lock Gel tube (Qiagen, MaXtract
High Density, catalog # 129065). The genome-wide genotyping
experiments were conducted by using the Affymetrix GenomeWide SNP Array 6.0 genotyping platform. 325 nanograms of
DNA per sample were prepared for both Sty1 and Nsp1 restriction
enzyme digestion for this assay, genotyping in according to the
manufacturer’s instructions.

Quality control
Patient DNA. Genotyping analysis of GWAS samples was
performed in Genotyping Console 3.0.2 for first-pass quality
control. The contrast quality control (CQC) metrics were computed
by the Affymetrix software. We attempted to ascertain genotypes for
1,104 NPC study subjects. 11 samples failed genotyping or were
removed because of failing CQC (,0.4) or call rate (,90%). An
additional 17 samples failed to meet further QC filters which
included heterozygosity , = 25% and at least one enzyme specific
CQC value (Nsp1 or Sty1) .1. 24 samples were removed because
the genotypes determined in the GWAS were discordant with
genotypes previously determined by the Laboratory of Genomic
Diversity for candidate gene studies. The gender of the samples was
determined from the heterozygosity of X chromosome SNPs
(Affymetrix and PLINK software) and by the ratio of the mean
intensity of the copy number probes on the Y chromosome to the
mean intensity of a subset of copy number probes on the X
chromosome (Affymetrix software). Four samples were removed
because the gender determined from the genotypes was discordant
with the gender provided by the cohort. Identity by descent (IBD)
statistics computed using PLINK software were used to detect
cryptic familial relationships. Four first degree relationships were

Materials and Methods
Ethics statement
This study were approved by institutional ethics review
committees at the relevant organizations, and conducted with
the IRB approval (NIH IRB -02-C-N056). Informed consent was
obtained from all study participants.

Study cohorts
A total of 4055 study subjects (1405 NPC cases and 2650
controls, Table S3) were recruited in two independent collection
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Figure 3. Proxy variant analysis for the strongest aa-variants or HLA allele in HLA-A, in HLA-B, and in HLA-C. Genetic association of
each HLA amino acid variant was calculated. Study participants in both phase I and phase II (N = 4055 study participants; Line V in Table S3).
Multivariate conditional logistic regression analysis was performed to compute amino acid variants (A, C, and E) or HLA alleles (B, D, and F) association
p-value. The HLA typing data set (N = 4055 study participants; Line V in Table S3) were used PLINK to examine the residual effect of index amino acid
variant or HLA allele while using other amino acid variant or HLA allele as a covariate, and we adjusted the results for age and gender. The index
amino acid variant or HLA allele was marked with bold red font. The red line indicated unadjusted –log10 p of index. Three HLA class I genes regions
were separated by light blue block of HLA-C gene between HLA-A and HLA-B. The X-axis is amino acid or HLA allele covariate, ranking by their
coordinate. HLA alleles were group together ranking by allele names in each HLA class I gene locus. The Y-axis is the –log10p of index variant adjust
by covariate. Independent variants should not change the adjusted p-values from the strong unadjusted values of the index variant, while LD-proxies
would reduce their p-values appreciably depending upon the strength of LD.
doi:10.1371/journal.pgen.1003103.g003
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observed (3 full sib pairs and 1 parent-offspring pair). For each of
these pairs, the sample with the lowest call rate was removed. A fifth
sample was removed because the IBD statistics were consistent with
that individual having a first cousin relationship with five other
subjects. After sample filtering, a number of 1043 subjects were
remained for further analyses (Table S2).
SNPs. Genotypes were ascertained for the 934,968 SNPs on
the Genome-wide SNP 6.0 platform using the command line
option of Affymetrix software. NetAffx version 30 was used for
SNP annotation. This data set uses map positions based on the
NCBI Build 36.1/UCSC hg18 human genome assembly. Unsupported SNPs, QC SNPs, non-autosomal SNPs, and remaining
redundant SNPs were identified from the annotation data set and
removed. Genotypes from 8 CEPH and 10 NPC mother/father/
offspring trios were checked for errors in Mendelian inheritance
using PLINK software. SNPs having 2 or more errors in either
group of samples were rejected. Per-SNP call rate, HardyWeinberg test statistics, and minor allele frequencies were
computed for 1,043 NPC study samples (see Table S2A) using
PLINK software. SNPs not meeting the criteria shown in the table
were removed (Table S2B).

genotyping results, we were able to define corresponding amino
acid sequences for all study subjects. The amino acid variants in
HLA class I genes were defined by using web-based software of the
Immunology Database and Analysis Portal (ImmPort) system [24].

Proxy SNP–variant analysis
We have used the method of testing each variant for reduced-pvalues in multi-variants models resulting from co-linearity of
variants to recognize LD and independence of signals in the
association of NPC with HLA-A, -B and -C. Multicollinearity in
logistic regression models is a result of strong correlations between
variables. The existence of multicollinearity (high r2) between
variants inflates the variances of the parameter estimates. That will
likely result in lowered p-values for a given SNP that was
determined to be in significant association with NPC when tested
signally. We used a reduction in significance as an indicator that
two variants were in strong LD, and therefore not independent
signals as has been done by recent authors [18]. This gives us a
general idea about independence of the signals within HLA and
adjacent genes within the context of the disease association.
However, we recognize that although multicollinearity may lower
magnitudes of regression coefficient estimates and resulting pvalue significance in cases of LD, this method may be subject to
error such as when a rare SNP on a haplotype does not have a
large effect on the model. These methods are provided as an
indicator of independence, but not as a definitive measure in our
understanding of the disease.

Replication genotyping
Validation and replication genotyping of significant SNPs from
our GWAS and from other studies was performed using the ABI
Taqman genotyping assays by design in accordance with the
manufacturer’s instructions. The sequence detection software
(SDS2.2, Applied Biosystems, Foster City, CA, USA) was used
for allelic discrimination and confirmed the good quality of
genotyping.

Statistical analysis
We performed logistic regression model analysis for all SNPs
passing the quality control filters, using a Cochran-Armitage trend,
co-dominant, dominant, recessive, and allelic model taking the
number of copies of the rare allele 0, 1 or 2, as the explanatory
variable. The comparisons were conducted between NPC cases and
NPC free controls, NPC cases and NPC-free but EBV-IgA/VCA
antibody positive controls (EP controls), NPC cases and NPC-free
but EBV-IgA/VCA-antibody negative controls (EN controls), EP
controls and EN controls respectively. Population structure/
stratification was assessed using the Principal Components Analysis
(PCA) module of Eigensoft software [33]. Study samples were first
run together with HapMap individuals of European, African, and
Asian descents to identify any potential admixed individuals. Later,
PCA analyses of only the study samples were conducted. Initially all
autosomal SNPs that passed the quality control filters were used to
estimate the contribution of each SNP to the top ten eigenvectors.
Previously reported correlated genome regions [19] (such as on
chromosomes 6, 8, and 11) were observed and excluded from the
following PCA analyses. Moreover, to avoid any confounders due to
LD among the SNPs, the genotype data was pruned to 90 K
independent SNPs distributed throughout the genome by PLINK
prior to the PCA analyses. The logistic regression analysis
performed using PLINK [25], controlling for gender, age and the
first three eigenvectors; the significance was evaluated using the log
likelihood test. SNPs were sorted according to the lowest P-value in
a combined set of samples in one of these models. The chi-square
tests were used for testing case-control association for allele effects.
HLA allele frequencies were calculated based on observed
genotypes; HLA-A, -B and -C haplotype were assigned based on
maximum likelihood estimation using the SAS/Genetics HAPLOTYPE procedure. The effect of HLA alleles on the development of
NPC and EBV-IgA/VCA antibody was evaluated by computing
odds ratios (OR) and 95% confidence intervals (CI) using logistic
regression. For HLA allele and haplotype test, P values were
calculated by logistic regression and then corrected by the

HLA typing
High resolution HLA molecular typing was performed for all
1,405 unrelated NPC cases and 2,650 unrelated controls from
both enrollment cohorts. HLA class I alleles were characterized
using a PCR-SSOP (sequence-specific oligonucleotide probe)
typing protocol developed by the 13th International Histocompatibility Workshop [32] for the first enrollment study cohort
(N = 985), and using a DNA sequence-based typing (SBT) protocol
in the second enrollment study cohort (N = 3070). The sequencing
analysis was performed using the ABI Big Dye Terminator Cycle
Sequencing Kit and the ABI3730xl DNA analyzer (Applied
Biosystems, Foster City, CA). HLA alleles were assigned on the
basis of the sequence database of known alleles with the help of the
ASSIGN software developed by Conexio Genomics (Conexio
Genomics, Western Australia, Australia). Ambiguous heterozygous
genotypes were resolved by additional PCR and sequencing
procedures using allele-specific PCR primers to selectively amplify
only one of the two alleles.
Haplotype of HLA-A, HLA-B and HLA-C allelic combinations
were assessed using 422 children of the phase I study subjects in
179 patients and 379 controls. Based on expectation maximization
algorithm to generate maximum likelihood estimation haplotype,
we observed 90% accuracy on HLA-A-B-C haplotypes, 91% on
HLA-A-B and HLA-A-C haplotypes, and 99% on HLA-B-C
haplotypes. For the remaining NPC cases and controls, HLA
haplotypes were assigned by population-based estimation methods
of PROC HAPLOTYPE in SAS/Genetics package.

HLA amino acid variant definition
Because the most significant NPC associated SNPs is located on
the HLA class I region (see Results), an amino acid analysis was
carried out to evaluate the role of functional relative amino acid
residues in HLA associations. From our high resolution HLA
PLOS Genetics | www.plosgenetics.org
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Table S3 Summary of samples used in GWAS, replication and
HLA analysis.
(DOCX)

Bonferroni, which was multiplied by the number of all detected
alleles or haplotypes. Significance was considered at P,0.05 after
correction.

Table S4 GWAS Results (N = 1,043 subjects) using different test
combinations and genetic models for 24 SNPs with the lowest p
values.
(DOCX)

Supporting Information
Figure S1 Plots of principal components from the PCA for
genetic matching. Plot of the first two PCs from the PCA
(N = 1043 study participants; Row I in Table S3)and 206 HapMap
individuals, including 57 Yoruba in Ibadan, Nigeria (YRI), 44
Japanese in Tokyo, Japan (JPT), 45 Han Chinese in Beijing,
China(CHB) and 60 CEPH (Utah residents with ancestry from
northern and western Europe) (CEU).
(TIF)

Table S5 List of 16 genetic association tests.

(DOCX)
Table S6 Replication of previously reported NPC associated
GWAS SNPs and candidate genes in these cohorts.
(DOCX)

Figure S2 Plots of principal components from the PCA for
genetic matching. Plot of the first two PCs from the PCA
(N = 1043 study participants; Row I in Table S3), 44 Japanese in
Tokyo, Japan (JPT), and 45 Han Chinese in Beijing, China (CHB).
(TIF)

Table S7 40 GWAS and validation of SNPs association data in
two independent NPC cohorts.
(DOCX)
Table S8 Significant explicit and imputed haplotype NPC

Figure S3 Plots of the first two principal components from the

association analysis.
(DOCX)

PCA of 1,043 NPC study samples for genetic matching.
(TIF)

Table S9

Association results for the amino acid residues in each
of the classical HLA loci in all study subjects.
(DOCX)

Figure S4 Plot of the first and third PCs from the PCA of 1,043
NPC study samples for genetic matching.
(TIF)

Table S10 The five most significant NPC associated amino acid
in each HLA class I locus.
(DOCX)

Figure S5 Plots of the second and third PCs from the PCA of
1,043 NPC study samples for genetic matching.
(TIF)

Table S11 Multivariate logistic regression analysis for significant
variant and HLA class I alleles.
(DOCX)

Figure S6 Quantile-quantile plot showing the distribution of

observed statistic by allelic test for association of each SNP with
NPC.
(TIF)

Table S12 HLA-A, -B and -C allele association analysis
separated into in phase I and II analyses.
(DOCX)

Figure S7 Schematic overview of the structure of HLA-A*11:01

in complex with SARS nucleocapsid peptide. The a1-helix is
shown in blue; a2-helix is shown in purple; b-pleated sheet is
shown in lightblue. The significantly associated exposed positons
of the peptide in the binding groove are shown in red with label
indicated. Green balls in the binding groove indicate SARS
nucleocapsid peptide K[T]FPPTEP[K], notice the P2 and P9
residues with red. The crystal structure of 1X7Q [13] was
download from PDB database (http://www.pdb.org/pdb/home/
home.do). (a) Top view, (b) P2 residueThreonine (Thr, T) in
peptide bingding groove, (c) P9 residue Lysine (Lys, K) in peptide
binding groove. All figures were prepared with PyMOL [14].
(TIF)
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